Rapkin Andrea J
Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1740, USA.
Am J Obstet Gynecol. 2007 Feb;196(2):97-106. doi: 10.1016/j.ajog.2006.05.056.
The decline in concentrations of gonadal hormones during menopause gives rise to a range of physiologic and psychologic changes that may impact a woman's health and quality of life significantly. Most notable among these are vasomotor symptoms (hot flashes and night sweats) and mood and sleep disturbances.
This article reviews the physiologic condition underlying menopausal vasomotor symptoms and centrally active, nonhormonal therapies that have demonstrated efficacy for their treatment.
Despite the emergence of a range of nonhormonal treatments for vasomotor symptoms, a need still exists for safe and effective therapeutic options that directly target the underlying thermoregulatory mechanisms for women who want treatment but prefer to avoid hormone therapy or for whom hormone therapy is contraindicated.
The availability of centrally active therapies for menopausal vasomotor symptoms with risks and benefits clearly defined by results from well-designed clinical trials has the potential to allay safety concerns that are associated with the treatment of these common symptoms.
更年期期间性腺激素浓度下降会引发一系列生理和心理变化,这些变化可能会对女性的健康和生活质量产生重大影响。其中最显著的是血管舒缩症状(潮热和盗汗)以及情绪和睡眠障碍。
本文回顾了更年期血管舒缩症状的生理基础以及已证明对其治疗有效的中枢活性非激素疗法。
尽管出现了一系列治疗血管舒缩症状的非激素疗法,但对于那些希望接受治疗但更倾向于避免激素疗法或激素疗法禁忌的女性来说,仍然需要直接针对潜在体温调节机制的安全有效的治疗选择。
通过精心设计的临床试验结果明确界定了风险和益处的更年期血管舒缩症状中枢活性疗法的可用性,有可能减轻与这些常见症状治疗相关的安全担忧。